ATE207119T1 - Die herstellung von menschlichen, monoklonalen antikörpern, die gegen das oberflächenantigen von hepatitis b aktiv sind - Google Patents

Die herstellung von menschlichen, monoklonalen antikörpern, die gegen das oberflächenantigen von hepatitis b aktiv sind

Info

Publication number
ATE207119T1
ATE207119T1 AT93900518T AT93900518T ATE207119T1 AT E207119 T1 ATE207119 T1 AT E207119T1 AT 93900518 T AT93900518 T AT 93900518T AT 93900518 T AT93900518 T AT 93900518T AT E207119 T1 ATE207119 T1 AT E207119T1
Authority
AT
Austria
Prior art keywords
hepatitis
monoclonal antibodies
production
human monoclonal
surface antigen
Prior art date
Application number
AT93900518T
Other languages
English (en)
Inventor
Lars G Ostberg
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Priority claimed from PCT/US1992/009749 external-priority patent/WO1994011495A1/en
Application granted granted Critical
Publication of ATE207119T1 publication Critical patent/ATE207119T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT93900518T 1992-11-06 1992-11-06 Die herstellung von menschlichen, monoklonalen antikörpern, die gegen das oberflächenantigen von hepatitis b aktiv sind ATE207119T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1992/009749 WO1994011495A1 (en) 1992-11-06 1992-11-06 Production of human monoclonal antibodies active against hepatitis b surface antigen

Publications (1)

Publication Number Publication Date
ATE207119T1 true ATE207119T1 (de) 2001-11-15

Family

ID=22231529

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93900518T ATE207119T1 (de) 1992-11-06 1992-11-06 Die herstellung von menschlichen, monoklonalen antikörpern, die gegen das oberflächenantigen von hepatitis b aktiv sind

Country Status (5)

Country Link
JP (1) JP2002502222A (de)
KR (1) KR100281163B1 (de)
AT (1) ATE207119T1 (de)
DE (1) DE69232140D1 (de)
RU (1) RU2146706C1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3298038B1 (de) * 2015-05-22 2021-08-04 Huahui Health Ltd. Anti-pre-s1-hbv-antikörper
MA45496A (fr) 2016-06-17 2019-04-24 Hoffmann La Roche Molécules d'acide nucléique pour la réduction de l'arnm de padd5 ou pad7 pour le traitement d'une infection par l'hépatite b
US10953034B2 (en) 2017-10-16 2021-03-23 Hoffmann-La Roche Inc. Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection
US11932681B2 (en) 2018-05-31 2024-03-19 Novartis Ag Hepatitis B antibodies

Also Published As

Publication number Publication date
JP2002502222A (ja) 2002-01-22
RU2146706C1 (ru) 2000-03-20
RU95117092A (ru) 1997-03-27
DE69232140D1 (de) 2001-11-22
KR950704478A (ko) 1995-11-20
KR100281163B1 (ko) 2001-04-02

Similar Documents

Publication Publication Date Title
CA2033640A1 (en) Vaccines against cancer and infectious diseases
AU2308595A (en) Monoclonal antibodies against hiv-1 and vaccines made thereo f
ATE188708T1 (de) Antikörperderivate
CA2149329A1 (en) Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
ATE168013T1 (de) Humanisierte chimäre anti-''icam-1'' antikörper, herstellungsverfahren und verwendung
CA2310888A1 (en) Monoclonal human natural antibodies
NO912645L (no) Fremgangsmaate til aa forbedre fiskers og krepsdyrs motstand mot sykdommer.
DK0807125T3 (da) Monoklonale antistoffer mod CD6 til behandling og diagnosticering af psoriasis
EP0313378A3 (de) Methoden und Zusammensetzungen für vorübergehende Elimination von humoralen immunen Antikörpern
ATE128627T1 (de) Immunomodulare mittel und deren verwendung.
GR3029774T3 (en) Method of preparing a radioactive rhenium complex solution.
ATE256148T1 (de) Menschliche monoklonale antikörper gegen das hepatitis b oberflächenantigen
DK341679A (da) Vaccine mod streptokokker og fremgangsmaade til fremstilling deraf
DE59608213D1 (de) Arzneimittel zur immuntherapie, enthaltend antikörper, die spezifisch das mhcii-antigen eines zu behandelnden patienten erkennen
ATE12660T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches thymozytantigen, antikoerper und verfahren zu seiner herstellung, diagnostische und therapeutische verwendungen und diesen antikoerper enthaltende pharmazeutische zusammensetzungen.
ATE207119T1 (de) Die herstellung von menschlichen, monoklonalen antikörpern, die gegen das oberflächenantigen von hepatitis b aktiv sind
EP0339163A3 (en) Monoclonal antibodies specific for hiv and hybridomas for their production
ATE105938T1 (de) Monoklonale antikörper gegen spezifische antigene regionen des humanen immundefizienzvirus und methoden zur verwendung.
DE3888887D1 (de) Monoklonale Antikörper gegen E7-Protein des Humanen Papillomvirus Typ 16, Verfahren zu ihrer Herstellung sowie ihre Verwendung.
NO951768L (no) Fremgangsmåte for fremstilling av monoklonale menneske-antistoffer som er aktive mot Hepatit B-overflateantigen
DE3855280D1 (de) Von mca 16-88 erkanntes antigen
ATE138200T1 (de) Das von mca-28a32 erkannte antigen
ATE21484T1 (de) An menschliche fibroblastenzellen adaptierte hepatitis-a-viren.
RU99116029A (ru) Применение mycobacterium vaccae для регуляции по типу отрицательной обратной связи th2-активности иммунной системы
ATE145335T1 (de) Kreuzreaktive immunisierung gegen influenza

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties